Intravenous Infusion Pumps Market Size, Growth, Trends, Revenue, Report 2022-2030

The global Intravenous Infusion Pumps market size is expected to be worth around US$ 10.4 billion by 2030, according to new report study.

The global Intravenous Infusion Pumps market size was valued at US$ 8.6 billion in 2020 and is anticipated to grow at a CAGR of 9.9% during forecast period 2021 to 2030.

Report Highlights

• Volumetric infusion pumps held the largest market share of 16.82% in 2021.
• Insulin infusion pumps are anticipated to register the highest CAGR over the forecast period.
• The pediatrics /neonatology segment held the largest market share of 26.6% in 2021.
• The Asia Pacific market is expected to witness a significant CAGR of 8.7% during the forecast period.
• North America dominated the market in 2021 and this trend is expected to continue throughout the forecast period.
• The U.S. held the largest market share of the North America.
• By product, the U.S. intravenous infusion pump market was valued at USD 248.6 billion in 2021 and expected to witness growth at a CAGR of 9.6% from 2022 to 2030.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38311

Growth Factors

 The introduction and development of specialty and smart pumps are imparting crucial growth of the market as they constitute Dose-error Reduction Software (DERS) and customized drug libraries. According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.

To improve the safety and efficacy of intravenous infusion pumps, the U.S. FDA took an initiative known as the Infusion Pump Improvement Initiative in 2010, which focuses on supporting the benefits of generic pumps and minimizing the risk associated with them at the same time. FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders. Several government collaborative research projects like the Generic Infusion Pump Project are introduced that are aimed at creating new methods for manufacturers for developing software for intravenous medical pumps. National Institute of Standards and Technology is working in collaboration with NCCoE to manufacture wireless medical pumps and such incorporation of various government policies and regulations will in turn propel the market.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38311

Scope of the Report

Product Insights

Volumetric infusion pumps held the largest market share of 16.82% in 2021. The high share of these pumps was due to them being capable of delivering continuous and very specific amounts of fluids at very slow to very fast rates. Based on product, the intravenous infusion pump market is segmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps.

The ambulatory infusion pumps, which are used to deliver liquid nutrients and medications to a patient in both emergency situations and for chronic conditions, contributed to a significant market share in 2021, as they are widely favored for the delivery of nutrients and medications.

The availability of other pumps like patient-controlled analgesia (PCA) pumps, insulin pumps, and smart pumps will contribute to the supplementary growth of this segment. The rising demand for enteral and syringe pumps is contributing to the burgeoning preference for the Intravenous Infusion pump which will also lead to segment growth. 

Lately, smart pumps with controlled IV medication and error-prevention software are widely used as these pumps are equipped with advanced features like drug libraries, which help in storing the amount of the medicated fluid given to the patient, and its barcode technology, which helps in the verification of a patient’s identity and also helps prevent drug administration errors.

On the other hand, insulin infusion pumps are anticipated to register the highest CAGR over the forecast period.  This is due to the fact that the global burden of diabetes and related complications has surged in the last decade mainly due to changing lifestyles and urbanization. This pump segment is expected to flourish in the latter future as it has a low incidence of infections and a low incidence of delivery system failure during treatment.

Disease Indication Insights          

The pediatrics /neonatology segment held the largest market share of 26.6% in 2021. Based on disease indication, the market has been segmented into chemotherapy diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology, and others. Pediatrics/Neonatology held the largest market share in 2021 owing to the fact that the treatment for pediatrics has advanced considerably and with the rising number of births globally the demand for effective pediatric care has also surged

This indicates that the segment uses intravenous infusion pumps predominantly for their medical procedures requiring the delivery of fluids at a customizable and precise programmed rate.

On the other hand, the haematology segment is estimated to advance significantly during the forecast period. With the rising incidences of surgeries and blood cancer (hemophilia), the demand for intravenous infusion pumps has seen a surge in hematology for treatments like blood transfusion, which is expected to increase in coming years.

Intravenous pumps are used for hematology as it is the only way that blood can be transfused into a patient’s body in a precise, compact, continuous manner. Moreover, the flow can be controlled manually or can be automated, avoiding the risk of failure during the treatment.

Regional Insights

The Asia Pacific market is expected to witness a significant CAGR of 8.7% during the forecast period. The regional countries are population-dense, with elevating burden of chronic diseases like diabetes, cardiovascular and cancer. These countries are also popular for their low cost of treatment and surgeries, thus being a preferred market for medical tourism.

Countries such as China, Japan, and India are emerging economies with well-developed healthcare infrastructure and facilities. Attributes like high disease burden, significant government reforms, adoption of new technology, and low cost of treatments are paving way for the market growth.

North America dominated the market in 2021 and this trend is expected to continue throughout the forecast period. Increasing Incidence of chronic diseases, an increasing number of surgical procedures performed, well-developed & increasing R&D, and escalating adoption of advanced technology in infusion pumps contributed to the growth of the market in this region.

The U.S. held the largest market share of the North America Intravenous Infusion market due to high disease prevalence, high medical R&D expenditure, and robust healthcare system. The prevalence of diabetes in the U.S. is also quite significant, which can be attributed to their lifestyle and stressed work environment. According to the Centre for Disease Control, 34.2 million population in the U.S. were diagnosed with diabetes in 2018 and the number is expected to elevate in the future.

Key Players

• Baxter International
• B. Braun Melsungen AG
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• CareFusion Corporation
• Fresenius Kabi
• Smiths Medical 

Market Segmentation

• Product Outlook
  • Infusion pumps
    • Volumetric Infusion pumps
    • Insulin Infusion pumps
    • Syringe Infusion pumps
    • Enteral Infusion pumps
    • Ambulatory Infusion pumps
    • Patient-Controlled Analgesia Infusion Pumps
    • Implantable Infusion pumps
    • Others
• Disease Indication Outlook
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others
• Regional Outlook 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38311

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333